Design Therapeutics, Inc. (DSGN) NASDAQ
10.17
-0.27(-2.59%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
10.17
-0.27(-2.59%)
Currency In USD
| Market Cap | 537.76M |
| Enterprise Value | 521.55M |
| P/E Ratio | -8.96 |
| PEG Ratio | 0.46 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.87 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -8.52 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.3 |
| Return On Equity | -0.33 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -622,000 |
| EBITDA | -78.85M |
| Net Income | -69.79M |
| Diluted EPS | -1.22 |
| Total Cash | 222.82M |
| Total Cash/Share | 3.63 |
| Total Debt | 2.73M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 22.28 |
| Book Value Per Share | 3.55 |
| 52-Week Change | 152.99 |
| 52-Week High | 17.25 |
| 52-Week Low | 3.33 |
| Moving Average 50 Days | 12.37 |
| Moving Average 200 Days | 9.26 |
| Average Volume | 691,073 |
| Shares Outstanding | 62.46M |
| % Held by Institutions | 66.26 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |